SCHEMBL7167278

SCHEMBL7167278

CCCOc1ccccc1C(=O)Nc1c(C)cccc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 2/20 0.53
NR1I2 O75469 1/20 0.53
CHRM2 P08172 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADRA2A P08913 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HIF1A Q16665 1/20 0.49
BRD4 O60885 1/20 0.47
HTT P42858 2/20 0.47
POLB P06746 1/20 0.47
RXFP1 Q9HBX9 2/20 0.46
PNLIP P16233 1/20 0.46
XBP1 P17861 1/20 0.46
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7160571 0.90 MAPT (0.55) MAPTMEN1KMT2AGAAKCNK3
SCHEMBL7163100 0.82 MAPT (0.58) MAPTMEN1KMT2ALMNANR1I2
SCHEMBL7167114 0.82 MAPT (0.60) MAPTMEN1KMT2ALMNARXFP1
SCHEMBL3352936 0.80 LMNA (0.79) MAPTMEN1KMT2ALMNANR1I2
Hydrochloric Acid SCHEMBL1239153 0.78 LMNA (0.77) MAPTMEN1KMT2ALMNANR1I2
Hydrochloric Acid SCHEMBL7831044 0.78 LMNA (0.77) MAPTMEN1KMT2ALMNANR1I2
SCHEMBL7718074 0.78 BRD4 (0.55) MAPTMEN1KMT2ALMNANR1I2
SCHEMBL7160516 0.78 KCNK3 (0.65) MAPTMEN1KMT2ALMNAHTT
SCHEMBL7960802 0.77 MEN1 (0.64) MAPTMEN1KMT2ALMNANR1I2
SCHEMBL9096182 0.77 MEN1 (0.55) MAPTMEN1KMT2ALMNANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
EP-0628032-B1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LTD (GB) 1998-05-13 EP disclosed
US-5482941-A Quinazolinone antianginal agents PFIZER INC. (US) 1996-01-09 US disclosed
EP-0628032-A1 QUINAZOLINONE ANTIANGINAL AGENTS Pfizer Limited (GB) 1994-12-14 EP disclosed
WO-1993012095-A1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LIMITED (GB) 1993-06-24 WO disclosed